Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Titian Software launches Mosaic 4.0

Product Image
Product Description

Titian Software has recently launched version 4.0 of its Mosaic Sample Management software. Mosaic is already established as the leading sample management software for small molecule compound libraries, and is used by ten of the top 20 pharma companies. Applications of the new Mosaic 4.0 are extended to the enterprise-wide management of biological samples and reagents in many different types of life science research organisations in industry and academia.

Mosaic 4.0 builds on the proven strengths of earlier versions, including modular scalability, advanced instrument integration, and comprehensive audit trail and genealogy tracking. In response to the specific requirements of biological sample management, Mosaic 4.0 now incorporates enhanced modules for tracking manually-accessed stores and manual operations, such as hand pipetting, for smaller-scale operations. A new built-in Substance Registration System handles the allocation of substance identifiers and the capture of substance metadata, and Mosaic can still seamlessly link to external registration systems if required. For higher-throughput laboratories, Mosaic 4.0 builds on its workflow management capability and wide array of integration modules for automated stores, liquid handlers and other instruments. The new functionality makes version 4.0 well-suited to the management of clinical trial samples and reagents, therapeutic and anti-drug antibodies (ADA), cell lines and biobank samples – in addition to small molecule compounds.

“The next generation Mosaic 4.0 was conceived in response to customer demand”, said Richard Fry, Titian’s Director of Business Development. “The new functionality to handle biological samples has been developed in close partnership with our customers in leading pharma and biotech companies, and I’m particularly pleased that the first installation of Mosaic 4.0 is in a validated environment in clinical trials. Our goal with version 4.0 is to build on our track record in compound management to establish Mosaic as the software of choice for the management of all sample types.”

Product Titian Software launches Mosaic 4.0
Company Titian Software
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified

Titian Software






Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Personality Traits, Psychiatric Disorders Linked to Specific Genomic Locations
Researchers have unearthed genetic correlations between personality traits and psychiatric disorders.
Forensic 3D Documentation of Skin Injuries
In this study, the validity of using photogrammetry for documenting injuries in a pathological context was demonstrated.
3-D Printed Dog’s Nose Improves Vapor Detection
By mimicking how dogs get their whiffs, a team of government and university researchers have demonstrated that “active sniffing” can improve by more than 10 times the performance of current technologies that rely on continuous suction to detect trace amounts of explosives and other contraband.
New Markers for Forensic Body-fluid Identification
University of Bonn researchers have successfully identified specific Micro-RNA signatures to help forensically identify body fluids.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Major Neuroscience Initiative Launched
Tianqiao and Chrissy Chen Institute invest $115 million to further expand neuroscience research, while Caltech construct $200 million biosciences complex.
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Scroll Up
Scroll Down

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!